137 related articles for article (PubMed ID: 37702124)
1. Don't SUMP it! Utility of PLAG1 immunocytochemistry in basaloid SUMP subcategory.
Sanchez-Avila M; Tjendra Y; Zuo Y; Ruiz-Cordero R; Garcia-Buitrago M; Jorda M; Gomez-Fernandez C; Velez Torres JM
Cancer Cytopathol; 2024 Jan; 132(1):60-68. PubMed ID: 37702124
[TBL] [Abstract][Full Text] [Related]
2. PLAG1: An Immunohistochemical Marker with Limited Utility in Separating Pleomorphic Adenoma from Other Basaloid Salivary Gland Tumors.
Avadhani V; Cohen C; Siddiqui MT
Acta Cytol; 2016; 60(3):240-5. PubMed ID: 27463119
[TBL] [Abstract][Full Text] [Related]
3. LEF-1: Diagnostic utility in distinguishing basaloid neoplasms of the salivary gland.
Schmitt AC; Griffith CC; Cohen C; Siddiqui MT
Diagn Cytopathol; 2017 Dec; 45(12):1078-1083. PubMed ID: 28972308
[TBL] [Abstract][Full Text] [Related]
4. Risk of malignancy associated with cytomorphology subtypes in the salivary gland neoplasm of uncertain malignant potential (SUMP) category in the Milan System: A bi-institutional study.
Chowsilpa S; An D; Lose H; Huang X; Nayar R; Maleki Z
Cancer Cytopathol; 2019 Jun; 127(6):377-389. PubMed ID: 31116514
[TBL] [Abstract][Full Text] [Related]
5. Recurrent rearrangements of the PLAG1 and HMGA2 genes in lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Andreasen S; von Holstein SL; Homøe P; Heegaard S
Acta Ophthalmol; 2018 Nov; 96(7):e768-e771. PubMed ID: 29437290
[TBL] [Abstract][Full Text] [Related]
6. Aspiration cytology of pleomorphic adenoma with squamous metaplasia: A case series and literature review illustrating diagnostic challenges.
Li JJX; Ng JKM; Lau EHL; Chan ABW
Diagn Cytopathol; 2022 Feb; 50(2):64-74. PubMed ID: 34927804
[TBL] [Abstract][Full Text] [Related]
7. Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts.
Katabi N; Ghossein R; Ho A; Dogan S; Zhang L; Sung YS; Antonescu CR
Hum Pathol; 2015 Jan; 46(1):26-33. PubMed ID: 25439740
[TBL] [Abstract][Full Text] [Related]
8. PLAG1 gene alterations in salivary gland pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: a combined study using chromosome banding, in situ hybridization and immunocytochemistry.
Martins C; Fonseca I; Roque L; Pereira T; Ribeiro C; Bullerdiek J; Soares J
Mod Pathol; 2005 Aug; 18(8):1048-55. PubMed ID: 15920557
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of PLAG1 immunohistochemical determination in salivary gland tumors.
Rotellini M; Palomba A; Baroni G; Franchi A
Appl Immunohistochem Mol Morphol; 2014; 22(5):390-4. PubMed ID: 23958548
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological effect of PLAG1 fusion genes in pleomorphic adenoma and carcinoma ex pleomorphic adenoma with special emphasis on histological features.
Asahina M; Saito T; Hayashi T; Fukumura Y; Mitani K; Yao T
Histopathology; 2019 Feb; 74(3):514-525. PubMed ID: 30307055
[TBL] [Abstract][Full Text] [Related]
11. PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities.
Katabi N; Xu B; Jungbluth AA; Zhang L; Shao SY; Lane J; Ghossein R; Antonescu CR
Histopathology; 2018 Jan; 72(2):285-293. PubMed ID: 28796899
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of translocation-associated immunohistochemical stains in the fine-needle aspiration diagnosis of salivary gland neoplasms.
Foo WC; Jo VY; Krane JF
Cancer Cytopathol; 2016 Jun; 124(6):397-405. PubMed ID: 26882287
[TBL] [Abstract][Full Text] [Related]
13. Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma.
de Brito BS; Giovanelli N; Egal ES; Sánchez-Romero C; Nascimento JS; Martins AS; Tincani ÁJ; Del Negro A; Gondak RO; Almeida OP; Kowalski LP; Altemani A; Mariano FV
Hum Pathol; 2016 Nov; 57():152-159. PubMed ID: 27473265
[TBL] [Abstract][Full Text] [Related]
14. Assessing the diagnostic accuracy for pleomorphic adenoma and Warthin tumor by employing the Milan System for Reporting Salivary Gland Cytopathology: An international, multi-institutional study.
Allison DB; Smith AP; An D; Miller JA; Shafique K; Song S; Viswanathan K; Eykman E; Rao RA; Wiles A; Barkan GA; Nayar R; Fadda G; Powers CN; Rossi ED; Siddiqui MT; Ali SZ; Kholová I; Layfield LJ; Field A; Baloch Z; Maleki Z
Cancer Cytopathol; 2021 Jan; 129(1):43-52. PubMed ID: 32767837
[TBL] [Abstract][Full Text] [Related]
15. HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma.
Mito JK; Jo VY; Chiosea SI; Dal Cin P; Krane JF
Histopathology; 2017 Oct; 71(4):511-521. PubMed ID: 28463429
[TBL] [Abstract][Full Text] [Related]
16. Aberrant PLAG1 expression in pleomorphic adenomas of the salivary gland: a molecular genetic and immunohistochemical study.
Matsuyama A; Hisaoka M; Nagao Y; Hashimoto H
Virchows Arch; 2011 May; 458(5):583-92. PubMed ID: 21394649
[TBL] [Abstract][Full Text] [Related]
17. PLAG1 alteration in carcinoma ex pleomorphic adenoma: immunohistochemical and fluorescence in situ hybridization studies of 22 cases.
Bahrami A; Dalton JD; Shivakumar B; Krane JF
Head Neck Pathol; 2012 Sep; 6(3):328-35. PubMed ID: 22485045
[TBL] [Abstract][Full Text] [Related]
18. Salivary gland neoplasms with basaloid features in the era of the Milan system for reporting salivary gland cytology: Classification and interobserver agreement.
Layfield LJ; Esebua M; Pantanowitz L; Maleki Z; Vazmitsel M; Baloch Z; Cantley RL; Schmidt R
Diagn Cytopathol; 2022 Jul; 50(7):341-349. PubMed ID: 35460214
[TBL] [Abstract][Full Text] [Related]
19. Utility of NR4A3 on FNA cytology smears and liquid-based preparations of salivary gland.
Millan N; Tjendra Y; Zuo Y; Jorda M; Garcia-Buitrago M; Velez-Torres JM; Gomez-Fernandez C
Cancer Cytopathol; 2022 Dec; 130(12):949-954. PubMed ID: 35913415
[TBL] [Abstract][Full Text] [Related]
20. Fine-Needle Aspiration Cytology of Cellular Basaloid Neoplasms of the Salivary Gland.
Cantley RL
Arch Pathol Lab Med; 2019 Nov; 143(11):1338-1345. PubMed ID: 31509452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
